Retirement + A.I. = Your New Edge While you analyze one ticker, A.I. is already three days ahead.
VantagePoint's patented A.I. processes thousands of intermarket correlations in milliseconds, forecasting price direction before it shows on any chart. That's up to 87.4% proven accuracy, backed by 35+ years of research.
In today's markets, manual analysis isn't just slower. It's losing.
The only question: are you using A.I., or competing against it?
Download your free guide and find out how to put it to work for your retirement portfolio.
DOWNLOAD FREE NOW |
| | Top Earnings NewsOndas Missed Expectations Ondas (ONDS) reported a loss of $0.39 per share on revenue of $30.11 million for the fourth quarter ended December 2025. The consensus estimate was a loss of $0.06 per share on revenue of $28.00 million. The Earnings Whisper number was a loss of $0.05 per share. The company missed expectations by 680.00% while revenue grew 629.26% on a year-over-year basis.
The company said it sees "meaningful upside" to its prior guidance for 2026 revenue of $170.0 million to $180.0 million. The current consensus revenue estimate is $175.0 million for the year ending December 31, 2026.
"2025 was a defining year for Ondas as we transitioned from a portfolio of advanced technologies into a scaled operating platform that has delivered substantial shareholder value over the past year and is positioned to continue to do so," said Eric Brock, Chairman and CEO of Ondas. "We delivered record financial results, highlighted by significant revenue growth across Ondas Autonomous Systems, and we enter 2026 with strong momentum, expanding backlog, and increasing global demand for our integrated autonomous systems solutions. Importantly, we have received strong support from our investors, as evidenced by approximately $1.5 billion of pro forma cash on our balance sheet as of December 31, 2025. This capital provides us with significant strategic flexibility to accelerate our growth initiatives, scale operations globally and execute on our Core + Strategic Growth Program, positioning Ondas to capture the substantial opportunities we see ahead in 2026 and beyond."
Ondas Holdings Inc., through its wholly owned subsidiary, Ondas Networks Inc., is a developer of proprietary, software-based wireless broadband technology for large established and emerging industrial markets. The Company’s standards-based, multi-patented, software-defined radio FullMAX platform enables Mission-Critical IoT (MC-IoT) applications by overcoming the bandwidth limitations of today’s legacy private licensed wireless networks. Ondas Networks’ customer end markets include railroads, utilities, oil and gas, transportation, aviation (including drone operators) and government entities whose demands span a wide range of mission critical applications. These markets require reliable, secure broadband communications over large and diverse geographical areas, many of which are within challenging radio frequency environments. Customers use the Company's FullMAX technology to deploy their own private licensed broadband wireless networks. The Company also offers mission-critical entities the option of a managed network service. Ondas Networks’ FullMAX technology supports IEEE 802.16s, the new worldwide standard for private licensed wide area industrial networks.

| Negative GuidanceCore Lab Guides Below Estimates Core Laboratories N.V. (CLB) said it expects first quarter earnings of $0.05 to $0.07 per share on revenue of $119.0 million to $123.0 million. The company's previous guidance was earnings of $0.11 to $0.15 per share on revenue of $124.0 million to $130.0 million, and the current consensus earnings estimate is $0.18 per share on revenue of $127.6 million for the quarter ending March 31, 2026.
Core Laboratories Inc. is a leading provider of proprietary and patented reservoir description and production enhancement services and products used to optimize petroleum reservoir performance.

Bionano Genomics Sees Revenue Below Estimates Bionano Genomics, Inc. (BNGO) said it expects first quarter revenue of $6.5 million to $6.7 million and revenue of $30.0 million to $33.0 million. The current consensus revenue estimate is $7.4 million for the quarter ending March 31, 2026 and revenue of $34.6 million for the year ending December 31, 2026.
Bionano is a genome analysis company providing tools and services based on its Saphyr system to scientists and clinicians conducting genetic research and patient testing, and providing diagnostic testing for those with autism spectrum disorder (ASD) and other neurodevelopmental disabilities through its Lineagen business.

|  | Braze is Expected to Beat Estimates Braze (BRZE) is confirmed to report earnings on Tuesday, March 24, 2026 at approximately 4:05 PM ET. The consensus earnings estimate is $0.14 per share on revenue of $198.19 million, respresenting 23.6% year-over-year revenue growth, and the Earnings Whisper ® number is $0.15 per share. Investors are 24.0% bearish going into the company's earnings release. Option traders are pricing in a 20.1% move on earnings and the stock has averaged a 12.2% move in recent quarters.

View Full Calendar
| |